Krüppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang

Yu Liu1, Jin-kun Wen, Li-hua Dong

  • 1Department of Biochemistry and Molecular Biology, Institute of Basic Medicine, Hebei Medical University, Shijiazhuang 050017, China.

Acta Pharmacologica Sinica
|December 29, 2009
PubMed
Abstract

Insights

Krüppel-like factor 5 (KLF5) activates cyclin D1 in vascular smooth muscle cells (VSMC) proliferation. This occurs via interaction with c-Jun, downstream of ERK and p38 MAPK pathways, in response to Ang II.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Cardiovascular research

Background:

  • Vascular smooth muscle cell (VSMC) proliferation is crucial in cardiovascular diseases.
  • Krüppel-like factor 5 (KLF5) is implicated in VSMC growth.
  • Understanding KLF5's role in cyclin D1 regulation is key.

Purpose of the Study:

  • To investigate the mechanism by which KLF5 activates cyclin D1 expression.
  • To elucidate the role of KLF5 in Angiotensin II (Ang II)-induced VSMC proliferation.

Main Methods:

  • Adenoviral vectors for KLF5 and c-Jun expression.
  • MTT assay and flow cytometry for cell growth analysis.
  • Luciferase and chromatin immunoprecipitation assays for gene regulation studies.

Main Results:

  • Ang II increased KLF5 expression and VSMC proliferation.
  • KLF5 activation by Ang II involves ERK and p38 MAPK pathways.
  • KLF5 and c-Jun interact to enhance cyclin D1 promoter activity.

Conclusions:

  • KLF5 is a downstream mediator of ERK/p38 MAPK signaling in Ang II-stimulated VSMCs.
  • KLF5, through interaction with c-Jun, drives cyclin D1 transcription.
  • This pathway is critical for Ang II-induced VSMC proliferation.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...